# Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)

> **NCT04602468** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Royal College of Surgeons, Ireland** · enrollment: 237 (actual)

## Conditions studied

- Cystic Fibrosis
- Cystic Fibrosis Liver Disease
- Cystic Fibrosis in Children
- Adherence, Medication
- Cystic Fibrosis Gastrointestinal Disease

## Interventions

- **DRUG:** Kaftrio

## Key facts

- **NCT ID:** NCT04602468
- **Lead sponsor:** Royal College of Surgeons, Ireland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-09-03
- **Primary completion:** 2029-04-01
- **Final completion:** 2029-07-01
- **Target enrollment:** 237 (ACTUAL)
- **Last updated:** 2024-05-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04602468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04602468, "Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04602468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*